ADAM17 cytoplasmic domain modulates Thioredoxin-1 conformation and activity

[1]  Bin Wang,et al.  Cytokine storm syndrome in coronavirus disease 2019: A narrative review , 2020, Journal of internal medicine.

[2]  D. Ragab,et al.  The COVID-19 Cytokine Storm; What We Know So Far , 2020, Frontiers in Immunology.

[3]  Ying Zhang,et al.  Redox regulation of tumor suppressor PTEN in cell signaling , 2020, Redox biology.

[4]  Q. Ye,et al.  The pathogenesis and treatment of the `Cytokine Storm' in COVID-19 , 2020, Journal of Infection.

[5]  Q. Ye,et al.  The pathogenesis and treatment of the `Cytokine Storm' in COVID-19 , 2020, Journal of Infection.

[6]  C. Rapezzi,et al.  COVID-19 in the heart and the lungs: could we “Notch” the inflammatory storm? , 2020, Basic Research in Cardiology.

[7]  Dean P. Jones,et al.  Reactive oxygen species (ROS) as pleiotropic physiological signalling agents , 2020, Nature Reviews Molecular Cell Biology.

[8]  M. Kopf,et al.  Thioredoxin-1 distinctly promotes NF-κB target DNA binding and NLRP3 inflammasome activation independently of Txnip , 2020, eLife.

[9]  G. Hardiman,et al.  Thioredoxin-1 improves the immunometabolic phenotype of antitumor T cells , 2019, The Journal of Biological Chemistry.

[10]  A. Taylor-Robinson,et al.  Decoding the enigma of antiviral crisis: Does one target molecule regulate all? , 2019, Cytokine.

[11]  Mario Prost.  System , 2019, Concepts for International Law.

[12]  F. Laurindo,et al.  Thioredoxin-1 Negatively Modulates ADAM17 Activity Through Direct Binding and Indirect Reductive Activity. , 2018, Antioxidants & redox signaling.

[13]  H. Forman,et al.  Redox control of cancer cell destruction , 2018, Redox biology.

[14]  F. Gräter,et al.  Accessibility explains preferred thiol-disulfide isomerization in a protein domain , 2017, Scientific Reports.

[15]  E. Rudiño-Piñera,et al.  Is dimerization a common feature in thioredoxins? The case of thioredoxin from Litopenaeus vannamei. , 2017, Acta crystallographica. Section D, Structural biology.

[16]  Nan Yang,et al.  McCulloch-Pitts Brains and Pseudorandom Functions , 2016, Neural Computation.

[17]  Quanhu Sheng,et al.  Optimization of Search Engines and Postprocessing Approaches to Maximize Peptide and Protein Identification for High-Resolution Mass Data. , 2015, Journal of proteome research.

[18]  Wei Wang,et al.  Protein folding guides disulfide bond formation , 2015, Proceedings of the National Academy of Sciences.

[19]  I. Polikarpov,et al.  RXR agonist modulates TR: corepressor dissociation upon 9-cis retinoic acid treatment. , 2015, Molecular Endocrinology.

[20]  Pietro Ghezzi,et al.  Linkage of inflammation and oxidative stress via release of glutathionylated peroxiredoxin-2, which acts as a danger signal , 2014, Proceedings of the National Academy of Sciences.

[21]  Jiankun Cui,et al.  Proteomic Quantification and Site-Mapping of S-Nitrosylated Proteins Using Isobaric iodoTMT Reagents , 2014, Journal of proteome research.

[22]  J. Scheller,et al.  A Disintegrin and Metalloprotease 17 Dynamic Interaction Sequence, the Sweet Tooth for the Human Interleukin 6 Receptor* , 2014, The Journal of Biological Chemistry.

[23]  Andrew R. Jones,et al.  ProteomeXchange provides globally co-ordinated proteomics data submission and dissemination , 2014, Nature Biotechnology.

[24]  R. Bhadra,et al.  NIH Public Access , 2014 .

[25]  A. Holmgren,et al.  Thioredoxin 1 Is Inactivated Due to Oxidation Induced by Peroxiredoxin under Oxidative Stress and Reactivated by the Glutaredoxin System* , 2013, The Journal of Biological Chemistry.

[26]  A. Tholey,et al.  Membrane-proximal domain of a disintegrin and metalloprotease-17 represents the putative molecular switch of its shedding activity operated by protein-disulfide isomerase. , 2013, Journal of the American Chemical Society.

[27]  F. Squina,et al.  Identification of Novel Interaction between ADAM17 (a Disintegrin and Metalloprotease 17) and Thioredoxin-1* , 2012, The Journal of Biological Chemistry.

[28]  O. Lunov,et al.  Thioredoxin-1 Promotes Anti-Inflammatory Macrophages of the M2 Phenotype and Antagonizes Atherosclerosis , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[29]  Wei-Li Di,et al.  Inflammatory skin and bowel disease linked to ADAM17 deletion. , 2011, The New England journal of medicine.

[30]  S. Tannenbaum,et al.  Site-specific and redox-controlled S-nitrosation of thioredoxin , 2011, Proceedings of the National Academy of Sciences.

[31]  Stefan Rose-John,et al.  ADAM17: a molecular switch to control inflammation and tissue regeneration. , 2011, Trends in immunology.

[32]  Edward L. Huttlin,et al.  A Tissue-Specific Atlas of Mouse Protein Phosphorylation and Expression , 2010, Cell.

[33]  C. Blobel,et al.  ADAM17 is regulated by a rapid and reversible mechanism that controls access to its catalytic site , 2010, Journal of Cell Science.

[34]  H. Masutani,et al.  Anti-oxidative, anti-cancer and anti-inflammatory actions by thioredoxin 1 and thioredoxin-binding protein-2. , 2010, Pharmacology & therapeutics.

[35]  J. Fox,et al.  New insights into the structural elements involved in the skin haemorrhage induced by snake venom metalloproteinases , 2010, Thrombosis and Haemostasis.

[36]  I. Mills,et al.  Thiol isomerases negatively regulate the cellular shedding activity of ADAM17. , 2010, The Biochemical journal.

[37]  M. Gooz.  ADAM-17: the enzyme that does it all , 2010, Critical reviews in biochemistry and molecular biology.

[38]  J. Tschopp,et al.  Thioredoxin-interacting protein links oxidative stress to inflammasome activation , 2010, Nature Immunology.

[39]  James Lani,et al.  ANOVA (Analysis of Variance) , 2010 .

[40]  Sun Joo Park,et al.  Thioredoxin-related protein 14, a new member of the thioredoxin family with disulfide reductase activity: implication in the redox regulation of TNF-alpha signaling. , 2009, Free radical biology & medicine.

[41]  A. Chauhan,et al.  Oxidative stress activates ADAM17/TACE and induces its target receptor shedding in platelets in a p38-dependent fashion. , 2009, Cardiovascular research.

[42]  M. Chopp,et al.  Tumorigenicity of cortical astrocyte cell line induced by the protease ADAM17 , 2009, Cancer science.

[43]  Goedele Roos,et al.  How Thioredoxin Dissociates Its Mixed Disulfide , 2009, PLoS Comput. Biol..

[44]  J. Arribas,et al.  ADAM17 as a therapeutic target in multiple diseases. , 2009, Current pharmaceutical design.

[45]  T. Sasazuki,et al.  Modulation of TNF-α-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-α production and facilitates viral entry , 2008, Proceedings of the National Academy of Sciences.

[46]  Dean P. Jones,et al.  Reactive aldehyde modification of thioredoxin-1 activates early steps of inflammation and cell adhesion. , 2007, The American journal of pathology.

[47]  M. Toledano,et al.  Disulfide Bond-mediated multimerization of Ask1 and its reduction by thioredoxin-1 regulate H(2)O(2)-induced c-Jun NH(2)-terminal kinase activation and apoptosis. , 2007, Molecular biology of the cell.

[48]  Steven P Gygi,et al.  Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry , 2007, Nature Methods.

[49]  Steven P Gygi,et al.  A probability-based approach for high-throughput protein phosphorylation analysis and site localization , 2006, Nature Biotechnology.

[50]  N. Hooper,et al.  Tumor Necrosis Factor-α Convertase (ADAM17) Mediates Regulated Ectodomain Shedding of the Severe-acute Respiratory Syndrome-Coronavirus (SARS-CoV) Receptor, Angiotensin-converting Enzyme-2 (ACE2) , 2005, Journal of Biological Chemistry.

[51]  D. Leppert,et al.  In pneumococcal meningitis a novel water-soluble inhibitor of matrix metalloproteinases and TNF-α converting enzyme attenuates seizures and injury of the cerebral cortex , 2004, Journal of Neuroimmunology.

[52]  E. Boja,et al.  Roles of TRP14, a Thioredoxin-related Protein in Tumor Necrosis Factor-α Signaling Pathways* , 2004, Journal of Biological Chemistry.

[53]  Birgit Schilling,et al.  MS2Assign, automated assignment and nomenclature of tandem mass spectra of chemically crosslinked peptides , 2003, Journal of the American Society for Mass Spectrometry.

[54]  L. Pannell,et al.  Intramolecular cross-linking experiments on cytochrome c and ribonuclease A using an isotope multiplet method. , 2002, Rapid communications in mass spectrometry : RCM.

[55]  Elias S. J. Arnér,et al.  Measurement of Thioredoxin and Thioredoxin Reductase , 2005, Current protocols in toxicology.

[56]  P. Schuck,et al.  Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. , 2000, Biophysical journal.

[57]  S. Targan,et al.  Role of cytokines in the pathogenesis of inflammatory bowel disease. , 2000, Annual review of medicine.

[58]  G. Powis,et al.  Crystal structures of reduced, oxidized, and mutated human thioredoxins: evidence for a regulatory homodimer. , 1996, Structure.

[59]  M. Feldmann,et al.  Role of cytokines in rheumatoid arthritis. , 1996, Annual review of immunology.

[60]  A. Holmgren,et al.  Mutagenesis of structural half-cystine residues in human thioredoxin and effects on the regulation of activity by selenodiglutathione. , 1993, Biochemistry.

[61]  R. Kuroki,et al.  Evidence for intramolecular disulfide bond shuffling in the folding of mutant human lysozyme. , 1991, The Journal of biological chemistry.

[62]  H. Eklund,et al.  Crystal structure of thioredoxin from Escherichia coli at 1.68 A resolution. , 1990, Journal of molecular biology.

[63]  A. Holmgren.  Bovine thioredoxin system. Purification of thioredoxin reductase from calf liver and thymus and studies of its function in disulfide reduction. , 1977, The Journal of biological chemistry.